MacroGenics | MGNX - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
AbbVie USD 3.84B 205M 2026-09
Amgen USD 1.68B 40M 2026-09
AstraZeneca USD 4.07B 1.73B 2026-09
Biogen USD 752M 42.3M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Daiichi Sankyo JPY 237.75B 12.21B 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Genmab DKK 205M 39M 2026-06
Geron USD 35.7M 3.16M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
J&J USD 6.25B 168M 2026-09
Karyopharm Therapeutics USD 10.42M 861K 2026-03
MacroGenics USD 7.9M 1.81M 2026-06
Merck USD 2.86B 25M 2026-09
Pfizer USD 3.28B 132M 2026-09
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Xencor USD 71.93M 5.61M 2026-09